Recombinant multi-species WTAP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WTAP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The Wilms tumor suppressor gene WT1 appears to play a role in both transcriptional and posttranscriptional regulation of certain cellular genes. This gene encodes a WT1-associating protein, which is a ubiquitously expressed nuclear protein. Like WT1 protein, this protein is localized throughout the nucleoplasm as well as in speckles and partially colocalizes with splicing factors. Alternative splicing of this gene results in several transcript variants encoding three different isoforms. [provided by RefSeq, Jul 2012]
The Alternative Names of target: 2810408K05Rik,9430038B09Rik,Female-lethal(2)D homolog (hFL(2)D),Mum2,Pre-mRNA-splicing regulator WTAP,RGD1563824,WT1-associated protein,WTAP,Wilms tumor 1-associating protein,Wtap
Go
to WTAP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13817-Ag-1/ GM-Tg-hg-IP13817-Ag-2 | Human WTAP protein | Human |
| GM-Tg-rg-IP13817-Ag-1/ GM-Tg-rg-IP13817-Ag-2 | Rat WTAP protein | Rat |
| GM-Tg-mg-IP13817-Ag-1/ GM-Tg-mg-IP13817-Ag-2 | Mouse WTAP protein | Mouse |
| GM-Tg-cynog-IP13817-Ag-1/ GM-Tg-cynog-IP13817-Ag-2 | Cynomolgus/Rhesus macaque WTAP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13817-Ag-1/ GM-Tg-felg-IP13817-Ag-2 | Feline WTAP protein | Feline |
| GM-Tg-cang-IP13817-Ag-1/ GM-Tg-cang-IP13817-Ag-2 | Canine WTAP protein | Canine |
| GM-Tg-bovg-IP13817-Ag-1/ GM-Tg-bovg-IP13817-Ag-2 | Bovine WTAP protein | Bovine |
| GM-Tg-equg-IP13817-Ag-1/ GM-Tg-equg-IP13817-Ag-2 | Equine WTAP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13817-Ag-1/ GM-Tg-hg-IP13817-Ag-2;
GM-Tg-rg-IP13817-Ag-1/ GM-Tg-rg-IP13817-Ag-2;
GM-Tg-mg-IP13817-Ag-1/ GM-Tg-mg-IP13817-Ag-2; GM-Tg-cynog-IP13817-Ag-1/ GM-Tg-cynog-IP13817-Ag-2; GM-Tg-felg-IP13817-Ag-1/ GM-Tg-felg-IP13817-Ag-2; GM-Tg-cang-IP13817-Ag-1/ GM-Tg-cang-IP13817-Ag-2; GM-Tg-bovg-IP13817-Ag-1/ GM-Tg-bovg-IP13817-Ag-2; GM-Tg-equg-IP13817-Ag-1/ GM-Tg-equg-IP13817-Ag-2 |
| Products Name | WTAP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | WTAP |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WTAP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.